ARCHIVES

The Clinical Trials Working Group: NCI panel considers plan to centralize clinical trial review and prioritization. NCI director faults system for duplication, “equivocal results.”

This article is from The Cancer Letter archive.

Vol. 30 No. 33 | August 13, 2004

Download PDF Visit The Full Archive

Related Articles

FDA Approves Taxotere For Node+ Breast Cancer

August 27, 2004

Academies Updates Guidelines on Stem Cell Research. NIH Begins New T-R01 Program.

September 19, 2008

NCI, IARC Sponsors Workshop On EBV

February 14, 1975

New Tool Found To Cut DNA At Any Position

April 4, 1986

In Brief: Moertel To Deliver Karnofsky Lecture; Hopkins, Cold Spring Harbor Receive Bristol-Myers Awards

April 25, 1986

In Brief: Pelayo Correa Heads LSU Cancer Center; Foundation to Honor Feinstein, Mack

September 5, 1997